Beta-Sitosterol and Prostate Health: The Cochrane Evidence

519 Men, 4 Trials 18-Month Follow-Up Data

Written by the Health Supplements Lab Editorial Team, drawing on the Cochrane/BJU International systematic review and its underlying trials.

Last reviewed September 2026

Beta-sitosterol doesn’t get the same attention as saw palmetto in most prostate-support marketing, but its evidence base is, if anything, more consistent. A systematic review pooling 519 men found a real, statistically significant effect — with one specific catch about which form actually works.

What It Is

Beta-sitosterol is a plant sterol — a cholesterol-like compound found in plants, including pine and spruce species, as well as the South African star grass Hypoxis rooperi. Unlike saw palmetto’s proposed DHT-blocking mechanism, beta-sitosterol is thought to work by reducing prostaglandin synthesis and interfering with cholesterol metabolism relevant to prostate tissue — a different pathway from most other prostate-support ingredients.

The Systematic Review

Wilt et al., 1999, BJU International and the Cochrane Database of Systematic Reviews. Four double-blind, placebo-controlled trials totaling 519 men with symptomatic BPH, lasting 4–26 weeks. Compared with placebo, beta-sitosterol improved IPSS symptom scores by 4.9 points (95% CI: 3.5–6.3) and peak urinary flow rate by 3.91 mL/s (95% CI: 0.91–6.90). Post-void residual volume also improved significantly. As with saw palmetto, beta-sitosterol did not reduce prostate size. Dropout rates were nearly identical between the treatment and placebo groups (7.8% vs. 8.0%), suggesting good tolerability.

The Form Matters

Three of the four trials in the review used “non-glucosidic” beta-sitosterol preparations. The one trial that used a different form — pure beta-sitosterol-beta-D-glucoside — showed no improvement in urinary flow measures. The reviewers’ own conclusion specifically credits the non-glucosidic form with the positive results. This is a real, specific, form-dependent finding worth knowing — not every product containing “beta-sitosterol” or “plant sterols” on its label is necessarily using the studied form.

Rare Long-Term Data

A rare 18-month extension. One of the four included trials (200 men, 20mg three times daily — 60mg/day total — for 26 weeks) followed patients into an open-label extension. Men who continued treatment maintained their improvement for the full 18 months. Men who had been on placebo and switched to beta-sitosterol caught up to the same level of improvement. Men who chose no further treatment saw their symptoms worsen slightly over time. Long-duration follow-up like this is genuinely uncommon in supplement research — most of what we cover on this site tops out at 12–26 weeks.

The reviewers were still appropriately cautious in their overall conclusion: the original trials were short, preparations weren’t standardized across studies, and long-term safety and BPH-complication prevention remain unknown even with this extension data.

How Real Products Compare

We checked the beta-sitosterol content in two prostate products we’ve reviewed:

Product	Dose
Life Extension Ultra Prostate Formula	180mg Beta-Sitosterol
Doctor’s Best Comprehensive Prostate Formula	~760mg (from 800mg CardioAid™ Plant Sterols, 95% purity)

Both exceed the 60mg/day dose used in the landmark long-term trial — Doctor’s Best considerably more so. Neither product’s label specifies whether the beta-sitosterol is in the non-glucosidic form shown effective in most of the reviewed trials, which is worth asking the manufacturer directly if this distinction matters to you.

FAQ

Does beta-sitosterol actually help with prostate symptoms?

A systematic review of 519 men found a real, statistically significant improvement in symptom scores and urine flow versus placebo — a more consistent result than the more debated saw palmetto evidence.

Does the form of beta-sitosterol matter?

Yes. Non-glucosidic forms showed real benefit in the reviewed trials; the one trial using a glucoside form showed no improvement in urinary flow measures.

What dose was used in the long-term study?

60mg/day (20mg three times daily), with benefits maintained for 18 months in patients who continued treatment.

Does it shrink the prostate?

No. Like saw palmetto, beta-sitosterol improves symptoms and urine flow without reducing prostate size structurally.

See how beta-sitosterol fits into our top-rated pick

Read Our Life Extension Ultra Prostate Review

Last reviewed: September 2026 · Read our full rating methodology · Clinical reference: Wilt et al., 1999, BJU International (PMID 10368239).